[go: up one dir, main page]

DK2148667T3 - Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme - Google Patents

Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme

Info

Publication number
DK2148667T3
DK2148667T3 DK08733752.3T DK08733752T DK2148667T3 DK 2148667 T3 DK2148667 T3 DK 2148667T3 DK 08733752 T DK08733752 T DK 08733752T DK 2148667 T3 DK2148667 T3 DK 2148667T3
Authority
DK
Denmark
Prior art keywords
hexol
cyclohexane
derivatives
treatment
eye diseases
Prior art date
Application number
DK08733752.3T
Other languages
English (en)
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2148667T3 publication Critical patent/DK2148667T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08733752.3T 2007-04-12 2008-04-11 Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme DK2148667T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92299807P 2007-04-12 2007-04-12
PCT/CA2008/000703 WO2008124940A1 (en) 2007-04-12 2008-04-11 Use of cyclohexanehexol derivatives in the treatment of ocular diseases

Publications (1)

Publication Number Publication Date
DK2148667T3 true DK2148667T3 (da) 2013-08-26

Family

ID=39863207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08733752.3T DK2148667T3 (da) 2007-04-12 2008-04-11 Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme

Country Status (12)

Country Link
US (2) US20100168250A1 (da)
EP (2) EP2656839A1 (da)
JP (1) JP2010523602A (da)
AU (1) AU2008238577B2 (da)
CA (1) CA2683607A1 (da)
DK (1) DK2148667T3 (da)
ES (1) ES2425264T3 (da)
HR (1) HRP20130768T1 (da)
PL (1) PL2148667T3 (da)
PT (1) PT2148667E (da)
SI (1) SI2148667T1 (da)
WO (1) WO2008124940A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
ES2453941T5 (es) 2005-11-30 2017-05-31 Abbvie Inc. Anticuerpos monoclonales contra la proteína beta amiloide y usos de los mismos
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
WO2010040232A1 (en) * 2008-10-09 2010-04-15 Waratah Pharmaceuticals Inc. Use of scyllo-inositols for the treatment of macular degeneration-related disorders
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies
WO2012149278A1 (en) 2011-04-29 2012-11-01 Allergan, Inc. Sustained release latanoprost implant
RU2683651C2 (ru) * 2013-06-18 2019-04-01 Иван Дмитриевич Захаров Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
US4454151A (en) 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
US4474806A (en) * 1982-05-10 1984-10-02 Merck & Co., Inc. Sulfonyl or carbonyl inositol derivatives useful as anti-inflammatory/analgesic agents
IT1164225B (it) 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
DE3405663A1 (de) 1984-02-17 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur herstellung von scyllo-inosit
US4952396A (en) * 1986-11-19 1990-08-28 Linus Pauling Institute Of Science & Medicine Method of using phytic acid for inhibiting tumor growth
US4758430A (en) * 1987-01-21 1988-07-19 Robert Sabin Method of treatment of Alzheimer's disease using phytic acid
US4847082A (en) * 1987-01-21 1989-07-11 Robert Sabin Method of treatment of Alzheimer's disease using phytic acid
JPH02184912A (ja) 1989-01-11 1990-07-19 Nec Corp パルス信号発生装置
JPH03102492A (ja) 1989-06-12 1991-04-26 Mitsui Eng & Shipbuild Co Ltd 自動販売機のデータ送信システムおよび複合機能型自動販売機
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
US5217959A (en) * 1990-09-06 1993-06-08 Robert Sabin Method of treating multiple sclerosis with phytic acid
JP2984043B2 (ja) 1990-09-18 1999-11-29 旭化成工業株式会社 ミオ・イノシトールデヒドロゲナーゼおよびその製造法
US5112814A (en) * 1990-10-24 1992-05-12 Robert Sabin Method of treatment of Parkinson's disease using phytic acid
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
JPH05192163A (ja) 1991-09-30 1993-08-03 Suntory Ltd イノシトールデヒドロゲナーゼ遺伝子
SE469260B (sv) * 1992-02-25 1993-06-14 Perstorp Ab En farmaceutisk komposition med foerbaettrad biotillgaenglighet avseende inositolfosfat
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
CA2146353C (en) * 1992-10-05 2007-04-17 Tomas Hudlicky Syntheses of d-chiro-3-inosose and (+)-d-chiro-inositol
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
US5972328A (en) * 1993-03-29 1999-10-26 Queen's University At Kingston Method for treating amyloidosis
ATE244302T1 (de) * 1993-04-05 2003-07-15 Aveve Nv Phytate-hydrolyse und enzymatische zusammensetzung für die hydrolyse von phytat
CN1072637C (zh) * 1993-08-11 2001-10-10 北兴化学工业株式会社 D－手性肌醇的制造方法
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US5858326A (en) * 1995-06-06 1999-01-12 Neurochem, Inc. Methods of increasing amyloid deposition
JP3630344B2 (ja) 1995-11-17 2005-03-16 北興化学工業株式会社 イノシトール立体異性体の製造方法
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US6232486B1 (en) * 1996-06-11 2001-05-15 Nutrimed Biotech Molecular probes and modulators for PI-PLC and PI 3-kinase
US5880099A (en) * 1996-09-20 1999-03-09 The Regents Of The University Of California Inositol polyphosphates and methods of using same
US5977078A (en) * 1996-09-20 1999-11-02 The Regents Of The Univesity Of California Inositol polyphosphate derivatives and methods of using same
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
US6153603A (en) * 1997-06-27 2000-11-28 Perstorp Ab Method of treating angiogenesis in tumor tissue
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
US6818430B1 (en) 1999-06-07 2004-11-16 Hokko Chemical Industry Co., Ltd. Process for producing L-epi-2-inosose and novel process for producing epi-inositol
US6329256B1 (en) * 1999-09-24 2001-12-11 Advanced Micro Devices, Inc. Self-aligned damascene gate formation with low gate resistance
AU784752B2 (en) * 1999-10-18 2006-06-08 Northern Innovations Holding Corp. Food supplement for increasing lean mass and strength
US7728043B2 (en) * 1999-10-22 2010-06-01 Kim Darrick S H L Methods for treatment of beta-amyloid protein-induced ocular disease
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
DE10031955A1 (de) * 2000-06-30 2002-01-17 Deutsches Krebsforsch Curcumin-Derivate mit gegenüber Curcumin verbesserter Wasserlöslichkeit und diese enthaltende Arzneimittel
ATE554763T1 (de) * 2001-02-06 2012-05-15 Quadra Logic Tech Inc Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation
EP1357945A2 (en) * 2001-02-06 2003-11-05 QLT Inc. Method to prevent vision loss
JP3981597B2 (ja) 2001-06-25 2007-09-26 北興化学工業株式会社 シロ−イノソースの製造法及びシロ−イノシトールの製造法
US20030181531A1 (en) 2003-02-11 2003-09-25 David Sherris Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
US6599891B2 (en) 2001-07-20 2003-07-29 Qlt Inc. Treatment of macular edema
US20040058313A1 (en) * 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
EP1644647B1 (de) 2003-07-05 2006-10-18 MAN B & W Diesel AG Axialgleitlager
EP2298870A1 (en) 2003-10-14 2011-03-23 Hokko Chemical Industry Co., Ltd. Method for producing scyllo-inositol
WO2006053428A1 (en) * 2004-11-17 2006-05-26 Joanne Mclaurin Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
WO2006112000A1 (ja) 2005-03-30 2006-10-26 The Niigata Institute Of Science And Technology 大腸菌変異株による２－デオキシ－シロ－イノソースの合成および精製する方法並びに得られた２－デオキシ－シロ－イノソース

Also Published As

Publication number Publication date
US20100168250A1 (en) 2010-07-01
SI2148667T1 (sl) 2013-12-31
WO2008124940A1 (en) 2008-10-23
AU2008238577B2 (en) 2015-02-19
EP2148667B1 (en) 2013-05-22
ES2425264T3 (es) 2013-10-14
JP2010523602A (ja) 2010-07-15
CA2683607A1 (en) 2008-10-23
EP2148667A1 (en) 2010-02-03
PL2148667T3 (pl) 2013-11-29
AU2008238577A1 (en) 2008-10-23
HRP20130768T1 (en) 2013-10-25
US20140135403A1 (en) 2014-05-15
EP2656839A1 (en) 2013-10-30
PT2148667E (pt) 2013-08-28
EP2148667A4 (en) 2010-06-02

Similar Documents

Publication Publication Date Title
DK2148667T3 (da) Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK1868600T3 (da) Spirocyklisk cyclohexanderivat til behandling af stofafhængighed
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2300443T3 (da) Triazolderivater, der er anvendelige til behandling af sygdomme
EP2212740A4 (en) EYOOPTIC LENS ELEMENT
BRPI0812361A2 (pt) Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
EP2077901A4 (en) OKULAR RADIOSURGERY
BRPI0919920A2 (pt) compostos para tratamento de doenças e desordens oftálmicas
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
BRPI0920137A2 (pt) implante ocular
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
BRPI0819241A2 (pt) Compostos derivados de amina para o tratamento de distúrbios e doenças oftálmicas
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
FR2913196B1 (fr) Implant oculaire accomodatif
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
ZA201001264B (en) 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus
DK2010184T3 (da) Implatanter til behandlingen af dopamin associerede tilstande
DE602008006709D1 (de) Funduskamera
BRPI0917440A2 (pt) composições farmacêuticas oftálmicas para o tratamento de patologias neoangiogênicas do olho
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme